POSTER SESSION III
Tuesday, March 27, 2007 — 9:30 AM - 12:00 Noon
Exhibit Hall B - 1
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
...then notice the 'Event Added' prompt in the toolbar above as feedback:
ENDOCRINE PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
76
Incidence and Survival of Thyroid Cancer with Follicular Phenotype — Papillary, Follicular, and Anaplastic
(451)
DE Henson, E Glazer, K Simpson, AM Schwartz, J Albores-Saavedra - The George Washington University, Washington, DC; LSUHSC, Shreveport, LA
Implications of the Changing Threshold for the Diagnosis of the Follicular Variant of Papillary Thyroid Carcinoma
(450)
K Guggisberg, S Widder, J Pasieka, M Khalil - University of Calgary and Calgary Lab Services, Calgary, AB, Canada; University of Calgary, Calgary, AB, Canada
NFκβ and HIF-1 a Pathways Are Down-Regulated in Follicular Thyroid Neoplasms but Not in Hyperplastic Nodules
(462)
S Rawlins, A Blanes, SJ Diaz-Cano - King’s College Hospital, London, England, United Kingdom; University of Malaga School of Medicine, Malaga, Spain
Molecular Markers of Follicular Variant Papillary Thyroid Carcinoma and Follicular Adenoma
(445)
K Denning, P Smyth, S Cahill, S Finn, E Conlon, JH Li, R Flavin, S Guenther, A Ferlinz, JJ O’Leary, O Sheils - Trinity College Dublin, Dublin, Ireland; Applied Biosystems, Foster City, CA
NF-κβ Activation Is Associated with Somatic and Germline RET Mutations in Medullary Thyroid Carcinoma
(449)
P Gallel, J Pallares, X Dolcet, D Llobet, M Encinas, V Palomar, D Mauricio, X Matias-Guiu - Hospital Universitari Arnau de Vilanova/University of Lleida, Lleida, Spain
S100A4 Expression Is Associated with Lymph Node Metastases in Papillary Microcarcinoma
(458)
HS Min, SH Park, SY Park - Seoul National University College of Medicine, Seoul, Korea; Seoul National Univeristy Bundang Hospital, Seongnam-si, Gyeonggi-do
MicroRNA Profiling of Papillary Thyroid Carcinoma Cell Lines
(466)
P Smyth, S Cahill, K Denning, J Li, SP Finn, S Guenther, R Henfrey, JJ O’Leary, O Sheils - Trinity College Dublin, Dublin, Ireland; Applied Biosystems, Foster City, CA
CK19 Can Improve the Prognostic Value of the WHO Classification of Pancreatic Endocrine Tumors
(463)
AM Schmitt, M Anlauf, S Schmid, F Riniker, J Bauersfeld, A Barghorn, PU Heitz, H Moch, P Komminoth, A Perren - Institute for Surgical Pathology, Zurich, Switzerland; Institute for Pathology, Kantonsspital Baden, Baden, Switzerland; Institute for Clinical Pathology, Kiel, Germany
Over-Expression of Cellular Prion Protein Is Unique in Pancreatic Endocrine Tumors
(453)
SJ Kim, J Xu, C Li, MS Sy, W Xin - Case Western Reserve University, Cleveland, OH; University Hospitals of Cleveland, Cleveland, OH
Expression of the Metastasis-Associated Gene 1 (MTA1) Is Associated with Malignant Behavior in Pancreatic Endocrine Tumors
(452)
MD Hofer, MC Chang, KA Lamb, MA Rubin, V Nose - Brigham and Women’s Hospital, Boston, MA
RET Expression Is Increased by Neuron-Like Differentiation of Pheochromocytoma and Normal Adult Chromaffin Cells
(461)
JF Powers, KL Picard, AS Tischler - Tufts New England Medical Center, Boston, MA
Clinical Significance of Crooke’s Cell Change in Pituitary Corticotroph Cell Adenomas
(467)
M Takei, H Kajiya, N Egashira, S Takekoshi, Y Ishii, S Tahara, S Teramoto, RY Osamura - Tokai University of School of Medicine, Isehara, Kanagawa, Japan; Nippon Medical School, Bunkyo-ku, Tokyo, Japan
Clinical and Morophological Characteristics of Functioning Pituitary Microadenomas and Macroadenomas: Analysis of Large Series
(468)
M Takei, H Kajiya, N Egashira, S Takekoshi, S Tahara, A Teramoto, RY Osamura - Tokai University School of Medicine, Isehara, Kanagawa, Japan; Nippon Medical School, Bunkyo-ku, Tokyo, Japan
button next to any title to add to Itinerary Planner...
Add
